HomeMCRB • NASDAQ
add
Seres Therapeutics Inc
Previous close
$8.67
Day range
$8.11 - $8.82
Year range
$6.54 - $29.98
Market cap
79.37M USD
Avg Volume
83.86K
P/E ratio
12.89
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 438.00K | — |
Operating expense | -26.42M | 11.63% |
Net income | -15.34M | 1.93% |
Net profit margin | -3.50K | — |
Earnings per share | -1.76 | 20.00% |
EBITDA | -18.42M | 33.61% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 45.77M | 48.62% |
Total assets | 138.19M | -1.16% |
Total liabilities | 93.98M | -25.43% |
Total equity | 44.22M | — |
Shares outstanding | 9.59M | — |
Price to book | 1.87 | — |
Return on assets | -34.40% | — |
Return on capital | -37.83% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -15.34M | 1.93% |
Cash from operations | -14.71M | 62.17% |
Cash from investing | 181.00K | 301.11% |
Cash from financing | 12.66M | 628.67% |
Net change in cash | -1.87M | 94.97% |
Free cash flow | -2.88M | 90.31% |
About
CEO
Founded
2010
Website
Employees
66
